Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbens

European Journal of Pharmacology

Volumn 578, Issue 2-3, 2008, Pages 185-193

  Lukkes, Jodi L ^a   Forster, Gina L ^a   Renner, Kenneth J ^a,b   Summers, Cliff H ^a,b  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b W O Farber Center for Civic Leadership   (United States)

Author keywords

Antalarmin; Antisauvigine 30; CRF receptor; Microdialysis; Stress

Indexed keywords

ANTALARMIN; ANTISAUVAGINE 30; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; SEROTONIN; URETHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; DRUG INFUSION; HYPOTHESIS; IN VIVO STUDY; MALE; MENTAL DISEASE; MICRODIALYSIS; NEUROPATHOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; STRESS;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PEPTIDE FRAGMENTS; PYRIMIDINES; PYRROLES; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEROTONIN; TIME FACTORS;

EID: 37349126918     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.09.024     Document Type: Article

References (88)

1. Amat J., Matus-Amat P., Watkins L.R., and Maier S.F. Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat. Brain Res. 812 (1998) 113-120
2. Amat J., Matus-Amat P., Watkins L.R., and Maier S.F. Escapable and inescapable stress differentially and selectively alter extracellular levels of 5-HT in the ventral hippocampus and dorsal periaqueductal gray of the rat. Brain Res. 797 (1998) 12-22
3. Amat J., Tamblyn J.P., Paul E.D., Bland S.T., Amat P., Foster A.C., Watkins L.R., and Maier S.F. Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala. Neuroscience 129 (2004) 509-519
4. Amato J.L., Bankson M.G., and Yamamoto B.K. Prior exposure to chronic stress and MDMA Potentiates mesoaccumbens dopamine release mediated by the 5-HT(1B) receptor. Neuropsychopharmacology 32 (2007) 946-954
5. Arborelius L., Owens M.J., Plotsky P.M., and Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 160 (1999) 1-12
6. Avgustinovich D.F., Alekseenko O.V., Bakshtanovskaia I.V., Koriakina L.A., Lipina T.V., Tenditnik M.V., Bondar' N.P., Kovalenko I.L., and Kudriavtseva N.N. Dynamic changes of brain serotonergic and dopaminergic activities during development of anxious depression: experimental study. Usp. Fiziol. Nauk 35 (2004) 19-40
7. Bakshi V.P., Smith-Roe S., Newman S.M., Grigoriadis D.E., and Kalin N.H. Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. J. Neurosci. 22 (2002) 2926-2935
8. Bale T.L., Picetti R., Contarino A., Koob G.F., Vale W.W., and Lee K.F. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J Neurosci. 22 (2002) 193-199
9. Bland S.T., Twining C., Schmid M.J., Der-Avakian A., Watkins L.R., and Maier S.F. Stress potentiation of morphine-induced dopamine efflux in the nucleus accumbens shell is dependent upon stressor uncontrollability and is mediated by the dorsal raphe nucleus. Neuroscience 126 (2004) 705-715
10. Bradberry C.W., Sprouse J.S., Aghajanian G.K., and Roth R.H. Sub-picogram determination of serotonin using HPLC with electrochemical detection for microdialysis studies of serotonin release. Adv. Exp. Med. Biol. 294 (1991) 81-89
11. Cardinal R.N., Pennicott D.R., Sugathapala C.L., Robbins T.W., and Everitt B.J. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 292 (2001) 2499-2501
12. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463 (2003) 235-272
13. Coccaro E.F. Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain-behavior relationship. Int. Clin. Psychopharmacol. 7 (1992) 3-12
14. Commons K.G., Connolley K.R., and Valentino R.J. A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology 28 (2003) 206-215
15. Day H.E., Greenwood B.N., Hammack S.E., Watkins L.R., Fleshner M., Maier S.F., and Campeau S. Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J. Comp Neurol. 474 (2004) 364-378
16. Deakin J.F. The role of serotonin in panic, anxiety and depression. Int. Clin. Psychopharmacol. 13 Suppl 4 (1998) S1-S5
17. Dremencov E., Newman M.E., Kinor N., Blatman-Jan G., Schindler C.J., Overstreet D.H., and Yadid G. Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment. Neuropharmacology 48 (2005) 34-42
18. Dunn A.J., and Berridge C.W. Is corticotropin-releasing factor a mediator of stress responses?. Ann. N. Y. Acad. Sci. 579 (1990) 183-191
19. Dunn A.J., and Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res. Rev. 15 (1990) 71-100
20. Evenden J.L., and Ryan C.N. The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl) 128 (1996) 161-170
21. Forster G.L., and Blaha C.D. Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area. Eur. J. Neurosci. 12 (2000) 3596-3604
22. Forster G.L., Feng N., Watt M.J., Korzan W.J., Mouw N.J., Summers C.H., and Renner K.J. Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior. Neuroscience 141 (2006) 1047-1055
23. Funk D., Li Z., Shaham Y., and Le A.D. Effect of blockade of corticotropin-releasing factor receptors in the median raphe nucleus on stress-induced c-fos mRNA in the rat brain. Neuroscience 122 (2003) 1-4
24. Giacalone E., Tansella M., Valzelli L., and Garattini S. Brain serotonin metabolism in isolated aggressive mice. Biochem. Pharmacol. 17 (1968) 1315-1327
25. Gold P.W., and Chrousos G.P. The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. Proc. Assoc. Am. Physicians 111 (1999) 22-34
26. Graeff F.G., Guimaraes F.S., De Andrade T.G., and Deakin J.F. Role of 5-HT in stress, anxiety, and depression. Pharmacol. Biochem. Behav. 54 (1996) 129-141
27. Gray T.S. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann. N. Y. Acad. Sci. 697 (1993) 53-60
28. Grigoriadis D.E., Liu X.J., Vaughn J., Palmer S.F., True C.D., Vale W.W., Ling N., and De Souza E.B. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors. Mol. Pharmacol. 50 (1996) 679-686
29. Grigoriadis D.E., Lovenberg T.W., Chalmers D.T., Liaw C., and De Souze E.B. Characterization of corticotropin-releasing factor receptor subtypes. Ann. N. Y. Acad. Sci. 780 (1996) 60-80
30. Hammack S.E., Richey K.J., Schmid M.J., LoPresti M.L., Watkins L.R., and Maier S.F. The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress. J. Neurosci. 22 (2002) 1020-1026
31. Hammack S.E., Pepin J.L., DesMarteau J.S., Watkins L.R., and Maier S.F. Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress. Behav. Brain Res. 147 (2003) 55-64
32. Hammack S.E., Schmid M.J., LoPresti M.L., Der-Avakian A., Pellymounter M.A., Foster A.C., Watkins L.R., and Maier S.F. Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. J. Neurosci. 23 (2003) 1019-1025
33. Harvey A.T., and Hennessy M.B. Corticotropin-releasing factor modulation of the ultrasonic vocalization rate of isolated rat pups. Brain Res. Dev. Brain Res. 87 (1995) 125-134
34. Haney M., Noda Y., Kream R., and Miczek K. Regional serotonin and dopamine activity; sensitivity to amphetamine and aggressive behavior in mice. Aggress. Behav. 16 (1990) 259-270
35. Ho S.P., Takahashi L.K., Livanov V., Spencer K., Lesher T., Maciag C., Smith M.A., Rohrbach K.W., Hartig P.R., and Arneric S.P. Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor. Brain Res. Mol. Brain Res. 89 (2001) 29-40
36. Hoffman C.S., Westin T.M., Miner H.M., Johnson P.L., Summers C.H., and Renner K.J. GABAergic drugs alter hypothalamic serotonin release and lordosis in estrogen-primed rats. Brain Res. 946 (2002) 96-103
37. Holahan M.R., Kalin N.H., and Kelley A.E. Microinfusion of corticotropin-releasing factor into the nucleus accumbens shell results in increased behavioral arousal and oral motor activity. Psychopharmacology (Berl) 130 (1997) 189-196
38. Ikemoto S., and Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res. Brain Res. Rev 31 (1999) 6-41
39. Izzo E., Sanna P.P., and Koob G.F. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor. Pharmacol. Biochem. Behav. 81 (2005) 701-708
40. Jacobs B.L., and Azmitia E.C. Structure and function of the brain serotonin system. Physiol Rev. 72 (1992) 165-229
41. Kalivas P.W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Brain Res. Rev 18 (1993) 75-113
42. Kirby L.G., Chou-Green J.M., Davis K., and Lucki I. The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res. 760 (1997) 218-230
43. Kirby L.G., Rice K.C., and Valentino R.J. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22 (2000) 148-162
44. Kirby L.G., Pernar L., Valentino R.J., and Beck S.G. Distinguishing characteristics of serotonin and non-serotonin-containing cells in the dorsal raphe nucleus: electrophysiological and immunohistochemical studies. Neuroscience 116 (2003) 669-683
45. Koob G.F., and Bloom F.E. Corticotropin-releasing factor and behavior. Fed. Proc. 44 (1985) 259-263
46. Le A.D., Harding S., Juzytsch W., Fletcher P.J., and Shaham Y. The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J. Neurosci 22 (2002) 7844-7849
47. LeMarquand D., Pihl R.O., and Benkelfat C. Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biol. Psychiatry 36 (1994) 326-337
48. LeMarquand D., Pihl R.O., and Benkelfat C. Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biol. Psychiatry 36 (1994) 395-421
49. Lowry C.A. Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis. J. Neuroendocrinol. 14 (2002) 911-923
50. Lowry C.A., Rodda J.E., Lightman S.L., and Ingram C.D. Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J. Neurosci. 20 (2000) 7728-7736
51. Merali Z., McIntosh J., Kent P., Michaud D., and Anisman H. Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala. J Neurosci. 18 (1998) 4758-4766
52. Merlo P.E., Lorang M., Yeganeh M., Rodriguez d.F., Raber J., Koob G.F., and Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci. 15 (1995) 5439-5447
53. Millan M.J. The neurobiology and control of anxious states. Prog. Neurobiol. 70 (2003) 83-244
54. Moghaddam B., and Bunney B.S. Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J. Neurochem. 53 (1989) 652-654
55. Nemeroff C.B. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol. Psychiatry 1 (1996) 336-342
56. Nemeroff C.B. The neurobiology of depression. Sci. Am. 278 (1998) 42-49
57. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 3rd ed. (1997), Academic Press, New York
58. Pecina S., Schulkin J., and Berridge K.C. Nucleus accumbens corticotropin-releasing factor increases cue-triggered motivation for sucrose reward: paradoxical positive incentive effects in stress?. BMC. Bioltechnol. 4 (2006) 8
59. Pennartz C.M., Groenewegen H.J., and Lopes da Silva F.H. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog. Neurobiol. 42 (1994) 719-761
60. Pernar L., Curtis A.L., Vale W.W., Rivier J.E., and Valentino R.J. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J. Neurosci. 24 (2004) 1305-1311
61. Peto C.A., Arias C., Vale W.W., and Sawchenko P.E. Ultrastructural localization of the corticotropin-releasing factor-binding protein in rat brain and pituitary. J. Comp Neurol. 413 (1999) 241-254
62. Petty F., Kramer G., Wilson L., and Jordan S. In vivo serotonin release and learned helplessness. Psychiatry Res. 52 (1994) 285-293
63. Plotsky P.M., Owens M.J., and Nemeroff C.B. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. North Am. 21 (1998) 293-307
64. Potter E., Behan D.P., Linton E.A., Lowry P.J., Sawchenko P.E., and Vale W.W. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc. Natl. Acad. Sci. U. S. A 89 (1992) 4192-4196
65. Price M.L., and Lucki I. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J. Neurosci. 21 (2001) 2833-2841
66. Price M.L., Curtis A.L., Kirby L.G., Valentino R.J., and Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 18 (1998) 492-502
67. Radulovic J., Sydow S., and Spiess J. Characterization of native corticotropin-releasing factor receptor type 1 (CRFR1) in the rat and mouse central nervous system. J Neurosci. Res. 54 (1998) 507-521
68. Radulovic J., Ruhmann A., Liepold T., and Spiess J. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J. Neurosci. 19 (1999) 5016-5025
69. Risbrough V.B., Hauger R.L., Pelleymounter M.A., and Geyer M.A. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology (Berl) 170 (2003) 178-187
70. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18 (1993) 247-291
71. Roy A., and Linnoila M. Suicidal behavior, impulsiveness and serotonin. Acta Psychiatr. Scand. 78 (1988) 529-535
72. Rueter L.E., and Jacobs B.L. A microdialysis examination of serotonin release in the rat forebrain induced by behavioral/environmental manipulations. Brain Res. 739 (1996) 57-69
73. Schulz D.W., Mansbach R.S., Sprouse J., Braselton J.P., Collins J., Corman M., Dunaiskis A., Faraci S., Schmidt A.W., Seeger T., Seymour P., Tingley III F.D., Winston E.N., Chen Y.L., and Heym J. CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc. Natl. Acad. Sci. U. S. A 93 (1996) 10477-10482
74. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., Chen R., Marchuk Y., Hauser C., Bentley C.A., Sawchenko P.E., Koob G.F., Vale W., and Lee K.F. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20 (1998) 1093-1102
75. Soubrie P. Serotonergic neurons and behavior. J. Pharmacol. 17 (1986) 107-112
76. Summers C.H., Kampshoff J.L., Ronan P.J., Lowry C.A., Prestbo A.A., Korzan W.J., and Renner K.J. Monoaminergic activity in subregions of raphe nuclei elicited by prior stress and the neuropeptide corticotropin-releasing factor. J. Neuroendocrinol. 15 (2003) 1122-1133
77. Summers C.H., Summers T.R., Moore M.C., Korzan W.J., Woodley S.K., Ronan P.J., Höglund E., Watt M.J., and Greenberg N. Temporal patterns of limbic monoamine and plasma corticosterone response during social stress. Neuroscience 116 (2003) 553-563
78. Takahashi L.K., Ho S.P., Livanov V., Graciani N., and Arneric S.P. Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety. Brain Res. 902 (2001) 135-142
79. Thomas E., Pernar L., Lucki I., and Valentino R.J. Corticotropin-releasing factor in the dorsal raphe nucleus regulates activity of lateral septal neurons. Brain Res. 960 (2003) 201-208
80. Tobin H., and Logue A.W. Self-control across species (Columba livia, Homo sapiens, and Rattus norvegicus). J. Comp. Psychol. 108 (1994) 126-133
81. Valentino R.J., Liouterman L., and Van Bockstaele E.J. Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus. J. Comp. Neurol. 435 (2001) 450-463
82. Van Bockstaele E.J., Biswas A., and Pickel V.M. Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens. Brain Res. 624 (1993) 188-198
83. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., and Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428 (2000) 191-212
84. Welch A.S., and Welch B.L. Effect of stress and para-chlorophenylalanine upon brain serotonin, 5-hydroxyindoleacetic acid and catecholamines in grouped and isolated mice. Biochem. Pharmacol. 17 (1968) 699-708
85. Wilkinson L.S., Humby T., Killcross S., Robbins T.W., and Everitt B.J. Dissociations in hippocampal 5-hydroxytryptamine release in the rat following Pavlovian aversive conditioning to discrete and contextual stimuli. Eur. J. Neurosci. 8 (1996) 1479-1487
86. Winstanley C.A., Theobald D.E., Dalley J.W., and Robbins T.W. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacology 30 (2005) 669-682
87. Wong M.L., Kling M.A., Munson P.J., Listwak S., Licinio J., Prolo P., Karp B., McCutcheon I.E., Geracioti Jr. T.D., DeBellis M.D., Rice K.C., Goldstein D.S., Veldhuis J.D., Chrousos G.P., Oldfield E.H., McCann S.M., and Gold P.W. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc. Natl. Acad. Sci. U. S. A 97 (2000) 325-330
88. Zangen A., Nakash R., Overstreet D.H., and Yadid G. Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens. Psychopharmacology (Berl) 155 (2001) 434-439